Posttranslational modification and mutation of histidine 50 trigger alpha synuclein aggregation and toxicity

[1]  T. Golde,et al.  Divergent effects of the H50Q and G51D SNCA mutations on the aggregation of α‐synuclein , 2014, Journal of neurochemistry.

[2]  G. Braus,et al.  Systematic Comparison of the Effects of Alpha-synuclein Mutations on Its Oligomerization and Aggregation , 2014, PLoS genetics.

[3]  J. Winkler,et al.  Autophagy modulates SNCA/α-synuclein release, thereby generating a hostile microenvironment , 2014, Autophagy.

[4]  H. Lashuel,et al.  The H50Q Mutation Enhances α-Synuclein Aggregation, Secretion, and Toxicity* , 2014, The Journal of Biological Chemistry.

[5]  E. Eisenmesser,et al.  Residue Histidine 50 Plays a Key Role in Protecting α-Synuclein from Aggregation at Physiological pH* , 2014, The Journal of Biological Chemistry.

[6]  Saikat Ghosh,et al.  The Parkinson's disease-associated H50Q mutation accelerates α-Synuclein aggregation in vitro. , 2013, Biochemistry.

[7]  D. Berg,et al.  SNCA: Major genetic modifier of age at onset of Parkinson's disease , 2013, Movement disorders : official journal of the Movement Disorder Society.

[8]  M. Farrer,et al.  Alpha‐synuclein p.H50Q, a novel pathogenic mutation for Parkinson's disease , 2013, Movement disorders : official journal of the Movement Disorder Society.

[9]  T. Schäffer,et al.  Oxidative stress-induced posttranslational modifications of alpha-synuclein: Specific modification of alpha-synuclein by 4-hydroxy-2-nonenal increases dopaminergic toxicity , 2013, Molecular and Cellular Neuroscience.

[10]  Christos Proukakis,et al.  A novel α-synuclein missense mutation in Parkinson disease , 2013, Neurology.

[11]  He-Jin Lee,et al.  Lipid peroxidation product 4-hydroxy-2-nonenal promotes seeding-capable oligomer formation and cell-to-cell transfer of α-synuclein. , 2013, Antioxidants & redox signaling.

[12]  J. Hardy,et al.  α-Synucleinopathy associated with G51D SNCA mutation: a link between Parkinson’s disease and multiple system atrophy? , 2013, Acta Neuropathologica.

[13]  B. Hyman,et al.  Alpha-synuclein aggregation involves a bafilomycin A1-sensitive autophagy pathway , 2012, Autophagy.

[14]  A. Brice,et al.  What genetics tells us about the causes and mechanisms of Parkinson's disease. , 2011, Physiological reviews.

[15]  Fred H. Gage,et al.  In vivo demonstration that α-synuclein oligomers are toxic , 2011, Proceedings of the National Academy of Sciences.

[16]  M. Ekberg,et al.  The lipid peroxidation products 4-oxo-2-nonenal and 4-hydroxy-2-nonenal promote the formation of α-synuclein oligomers with distinct biochemical, morphological, and functional properties. , 2011, Free radical biology & medicine.

[17]  H. Jäckle,et al.  Pre‐fibrillar α‐synuclein variants with impaired β‐structure increase neurotoxicity in Parkinson's disease models , 2009, The EMBO journal.

[18]  E. Waxman,et al.  Molecular mechanisms of alpha-synuclein neurodegeneration. , 2009, Biochimica et biophysica acta.

[19]  H. Ischiropoulos,et al.  Molecular Neurodegeneration BioMed Central Review , 2009 .

[20]  Henning Stahlberg,et al.  The fold of α-synuclein fibrils , 2008, Proceedings of the National Academy of Sciences.

[21]  D. D. Di Monte,et al.  Effect of 4-Hydroxy-2-nonenal Modification on α-Synuclein Aggregation* , 2007, Journal of Biological Chemistry.

[22]  H. Inoko,et al.  Multiple candidate gene analysis identifies alpha-synuclein as a susceptibility gene for sporadic Parkinson's disease. , 2006, Human molecular genetics.

[23]  Isidre Ferrer,et al.  Evidence of Oxidative Stress in the Neocortex in Incidental Lewy Body Disease , 2005, Journal of neuropathology and experimental neurology.

[24]  A Dürr,et al.  Causal relation between α-synuclein locus duplication as a cause of familial Parkinson's disease , 2004, The Lancet.

[25]  Philippe Amouyel,et al.  α-synuclein locus duplication as a cause of familial Parkinson's disease , 2004, The Lancet.

[26]  J. Hoenicka,et al.  The new mutation, E46K, of α‐synuclein causes parkinson and Lewy body dementia , 2004, Annals of neurology.

[27]  C. Becker,et al.  Conserved High Affinity Ligand Binding and Membrane Association in the Native and Refolded Extracellular Domain of the Human Glycine Receptor α1-Subunit* , 2004, Journal of Biological Chemistry.

[28]  Janel O. Johnson,et al.  α-Synuclein Locus Triplication Causes Parkinson's Disease , 2003, Science.

[29]  K. Uchida,et al.  4-Hydroxy-2-nonenal: a product and mediator of oxidative stress. , 2003, Progress in lipid research.

[30]  T. Montine,et al.  Hydroxynonenal adducts indicate a role for lipid peroxidation in neocortical and brainstem Lewy bodies in humans , 2002, Neuroscience Letters.

[31]  J Q Trojanowski,et al.  Aggregation of alpha-synuclein in Lewy bodies of sporadic Parkinson's disease and dementia with Lewy bodies. , 1998, The American journal of pathology.

[32]  Robert L. Nussbaum,et al.  Mutation in the α-Synuclein Gene Identified in Families with Parkinson's Disease , 1997 .

[33]  N. Hattori,et al.  Immunohistochemical detection of 4-hydroxynonenal protein adducts in Parkinson disease. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[34]  A. Schapira,et al.  A Novel Alpha-Synuclein Missense Mutation in Parkinson's Disease , 2012 .

[35]  H. Lashuel,et al.  Provided for Non-commercial Research and Educational Use Only. Not for Reproduction, Distribution or Commercial Use. Author's Personal Copy Role of Post-translational Modifications in Modulating the Structure, Function and Toxicity of A-synuclein: Implications for Parkinson's Disease Pathogenesis an , 2022 .

[36]  D. D. Di Monte,et al.  Effect of 4-hydroxy-2-nonenal modification on alpha-synuclein aggregation. , 2007, The Journal of biological chemistry.

[37]  A Dürr,et al.  Causal relation between alpha-synuclein gene duplication and familial Parkinson's disease. , 2004, Lancet.

[38]  Philippe Amouyel,et al.  Alpha-synuclein locus duplication as a cause of familial Parkinson's disease. , 2004, Lancet.

[39]  A. Singleton,et al.  alpha-Synuclein locus triplication causes Parkinson's disease. , 2003, Science.

[40]  R. Krüger,et al.  Ala30Pro mutation in the gene encoding alpha-synuclein in Parkinson's disease. , 1998, Nature genetics.

[41]  S E Ide,et al.  Mutation in the alpha-synuclein gene identified in families with Parkinson's disease. , 1997, Science.

[42]  H. Esterbauer,et al.  Chemistry and biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehydes. , 1991, Free radical biology & medicine.